Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Post by SamV21on Mar 10, 2023 5:22pm
146 Views
Post# 35331838

Google ards research no mention of Tetra at all.

Google ards research no mention of Tetra at all.https://www.globenewswire.com/en/news-release/2021/12/23/2357113/0/en/Acute-Respiratory-Distress-Syndrome-Pipeline-Drugs-and-Companies-Report-Analysis-of-Clinical-Trials-Therapies-Mechanism-of-Action-Route-of-Administration-and-Developments.html.........................................LOTS OF OTHER COMPANIES IN PHASE 3 TRIALS, PHASE ONE IS A MONEY AND TIME WASTER LIKE EVERYTHING ELSE GUY DOES.
I THOUGHT THERE WAS A PRIMARY COMPANY IN THIS RESEARCH AND TETRA WAS ONLY A SMALL PART OF THE TRIAL MEDICATION BEING USED , AS PER USUAL GUY MAKES IT SOUND LIKE IT IS  ALL TETRA DOING ANY OR ALL THE WORK WHEN HE HAS JUST CONTRACTED ANOTHER COMPANY WITH OUR MONEY. AS PER USUAL HAVE TO READ THE FINE PRINT I GUESS.  PHASE ONE IS 10 YEARS AWAY FROM ANY PRODUCT ! 
<< Previous
Bullboard Posts
Next >>